ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658441 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658441; 2) Community: the network communities that were significantly associated with the response to NSC 658441; 3) Molecule: the relationships between components within communities and NSC 658441; 4) MDR: the compounds that were significantly associated with the NSC 658441.

NSC Compound Enrichment Correlation
NSC 746498 Null 0.0288643166506692 0.29488433
NSC 752329 (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine 0.0288643166506692 0.13428891
NSC 756193 GSK978744A 0.0288643166506692 0.31770631
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0288643166506692 0.37488607
NSC 78312 Null 0.0288643166506692 0.0915688
NSC 95779 Null 0.0288643166506692 0.38960771
NSC 34821 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2-nitro phenyl)-, hydrochloride 0.0293341670043646 0.69438631
NSC 113943 6-Bromosangivamycin 0.0295480456086945 0.30734707
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0295480456086945 0.56012194
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0295480456086945 0.54616313
Total:115  Current:77    [First] [Prev] [Next] [Last]